Veracyte reported $50.04M in Current Liabilities for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acceleron Pharma XLRN:US $ 57.37M 2.11M
Agilent A:US $ 1708M 16M
Anika Therapeutics ANIK:US $ 28.77M 12.6M
Arrowhead Research ARWR:US $ 146.54M 48.9M
Biocept BIOC:US $ 10.4M 0.75M
Bruker BRKR:US $ 919.5M 35.1M
Dicerna Pharmaceuticals DRNA:US $ 239.3M 31.64M
Exact Sciences EXAS:US $ 710.23M 34.53M
Genmark Diagnostics GNMK:US $ 44.13M 3.46M
Heron Therapeutics HRTX:US $ 72.3M 9.85M
Illumina ILMN:US $ 914M 40M
Immunogen IMGN:US $ 111.78M 8.53M
Intrexon XON:US $ 28.99M 0.12M
Karyopharm Therapeutics KPTI:US $ 68.87M 10.74M
Laboratory Of America LH:US $ 2888.4M 221.3M
Ligand Pharmaceuticals LGND:US $ 36.3M 16.2M
Luminex LMNX:US $ 57.56M 29.9M
Myriad Genetics MYGN:US $ 203.2M 67.8M
Rigel Pharmaceuticals RIGL:US $ 59.28M 0.26M
Sangamo Biosciences SGMO:US $ 131.9M 5.04M
Siemens SIE:GR € 39952M 257M
Sonic Healthcare SHL:AU $ 2.22B 61.02M
Thermo Fisher Scientific TMO:US $ 7753M 828M
Veracyte VCYT:US $ 50.04M 13.93M
Waters WAT:US $ 1613.62M 932.6M